Form 4: Bruker Corp Executive Falko Busse Reports Stock Option Exercises and Sales
SEC Form 4 Filing
Falko Busse, President of the BioSpin Group at Bruker Corp, exercised stock options and sold shares on February 28, 2024.
Summary
- On February 28, 2024, Falko Busse, President of the BioSpin Group at Bruker Corp, engaged in transactions involving Bruker Corp's common stock.
- Busse exercised stock options to acquire a total of 28,122 shares at prices of $19.82, $22.19, $34.02, and $41.95.
- Concurrently, Busse sold 28,122 shares of common stock at weighted average prices of $86.06, $84.97 and $84.48.
- Following these transactions, Busse directly owns 32,859 shares of Bruker Corp common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. These filings are monitored by investors for insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may be interested in these transactions as they provide insight into an executive's view of the company's stock value.
Key Dates
| Date | Description |
|---|---|
| 08/07/2015 | Original grant date of stock option that vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
| 10/04/2016 | Original grant date of stock option that vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
| 08/09/2018 | Original grant date of stock option that vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
| 08/08/2019 | Original grant date of stock option that vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
| 02/28/2024 | Date of stock option exercises and sales. |
| 03/01/2024 | Date of signature on the Form 4 filing. |
| 08/07/2025 | Expiration date of stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.